Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by kstantzoon Sep 16, 2016 12:06am
70 Views
Post# 25243563

RE:RE:RE:Second Reading on the UK Drug Bill in the House of Commons

RE:RE:RE:Second Reading on the UK Drug Bill in the House of Commons
LaticelnExile wrote:
Craigbad wrote: Could be an early Christmas present! The "growth" was supposed to come from the Uk. This could be the nail in the coffin. Government in the Uk works quick, the loophole was just exposed a short time ago. They better sell this dumpster fire quick before private equity finds out about the upcoming price controls if they thought brexit was a bump! Lol

LaticelnExile wrote: ... will be on October 5, 2016!  

Who on this board said something about 2017 ?  


Oops.  I meant Monday October 10, (not October 5th), 2016.  But it does looks like its a present that will keep on giving before Christmas!   AMCo has gamed the system by having  their branded drug approved by the NHS but then later asking the NHS to strip the brand name from the drug thus making it generic.  Concordia then even calls it a "pipeline launch"  (which is why investors never get to hear the names of their new drug launches, and just hear "we have launched 13 in the quarter and we can't divulge the names because of prioprietary reasons...."   (How doped do they think investors are?   Aren't the reps selling these "secret" drugs?  Aren't they in the NHS tariff books if anyone wants to check?  What a lame excuse).  Once they have the brand name stripped to make it a generic  AMCo can raise prices on the drugs as much as they want.  The NHS assumes that competition will keep generic prices low.  However in AMCo's case, where their drugs have such a small market, they have been able to leverage their pure play generic capabilities.  It really was a brilliant scheme.  Except for the fact that they were caught and now the NHS knows their game.



Are you saying there was insurance fraud in the UK against the National Health System!?  
If that's the case, if I was British, I would be upset.

The government run institution is in financial crisis because of cost overruns. 

This is in fact "a worst storm" that anyone could have imagined just over a month ago.

Has anyone researched and summarized the CInven hold they have on AMCo?  What happens is payment of earnouts are not done with 50% deferred until Feb 2017 at 8% interest accrued daily.?

I was sure I saw it was posted but I can't find it.  It seems to have been erased?

<< Previous
Bullboard Posts
Next >>